Profile data is unavailable for this security.
About the company
EKF Diagnostics Holdings plc is a United Kingdom-based diagnostics company. The Company is engaged in point-of-care testing, central laboratory tests, enzyme manufacturing and the provision of contract manufacturing services to the healthcare industry. Its principal activity is the development, manufacture and supply of products into the in-vitro diagnostics marketplace. Its point of care analyzers is designed for use within doctors' surgeries, clinics, blood banks and hospital and private laboratories to provide results. Its life sciences specialize in producing enzymes and contracted custom products for use in medical diagnostics, pharmaceuticals and industry. Its life science facilities are based in two locations in Indiana, United States. Its central laboratory division manufactures a spectrum of reagents for use in hospital laboratories. Its contract manufacturing business provides specialized services to the diagnostics and healthcare industries for the production of custom kits.
- Revenue in GBP (TTM)52.61m
- Net income in GBP2.35m
- Incorporated2002
- Employees317.00
- LocationEKF Diagnostics Holdings PLCAvon HSE, 19 Stanwell RoadPENARTH CF64 2EZUnited KingdomGBR
- Phone+44 29 2071 0570Fax+44 29 2070 5715
- Websitehttps://www.ekfdiagnostics.com/
Peer analysis
Company | Revenue (TTM) | Net income (TTM) |
---|---|---|
Windar Photonics PLC | 2.38m | -591.07k |
ANGLE plc | 1.82m | -22.28m |
Kromek Group PLC | 17.62m | -4.10m |
Water Intelligence PLC | 59.59m | 3.21m |
EKF Diagnostics Holdings PLC | 52.61m | 2.35m |
Strix Group PLC | 144.59m | 16.20m |
Ab Dynamics PLC | 103.98m | 13.63m |
Institutional shareholders
Holder | Shares | % Held |
---|---|---|
Harwood Capital LLPas of 22 Mar 2024 | 132.35m | 29.17% |
Liontrust Investment Partners LLPas of 20 Mar 2024 | 54.42m | 11.99% |
Gresham House Asset Management Ltd. (Investment Management)as of 20 Mar 2024 | 49.79m | 10.97% |
Link Fund Solutions Ltd.as of 29 Dec 2023 | 34.01m | 7.50% |
Schroder Investment Management Ltd.as of 20 Mar 2024 | 24.51m | 5.40% |
Jarvis Investment Management Ltd.as of 01 Mar 2024 | 7.26m | 1.60% |
Joh. Berenberg, Gossler & Co. KG (Investment Management)as of 30 Dec 2022 | 6.86m | 1.51% |
Octopus Investments Ltd.as of 01 Mar 2024 | 6.14m | 1.35% |
AXA Investment Managers UK Ltd.as of 01 Mar 2024 | 5.34m | 1.18% |
KW Investment Management Ltd.as of 01 Mar 2024 | 5.08m | 1.12% |